⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Relmada Therapeutics, Inc. Common Stock

$4.43
+0.05 (+1.14%)

Volume:

662.178K ($2.93M)

Market Capitalization:

$472.55M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Relmada Therapeutics Market Segments

Overnight

*No Trades in Segment

After Hours

-0.01(-0.11%)
Open$4.44
Close$4.43
Low$4.43
Low Change-0.01 (-0.11%)
High$4.44
High Change+0.00 (+0.00%)
Range$0.01
Volume63.218K
Dollar Volume$280.06K

Regular Trading Hours

+0.08(+1.84%)
Open$4.35
Close$4.43
Low$4.32
Low Change-0.03 (-0.69%)
High$4.44
High Change+0.09 (+2.07%)
Range$0.12
Volume598.96K
Dollar Volume$2.65M

Premarket

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$4.37
Close$4.37
Low$4.37
Low Change0.00 (0.00%)
High$4.37
High Change+0.00 (+0.00%)
Range$0.00
Volume71.499K
Dollar Volume$312.45K

Regular Trading Hours Yesterday

-0.18(-3.95%)
Open$4.56
Close$4.38
Low$4.33
Low Change-0.23 (-5.04%)
High$4.58
High Change+0.02 (+0.44%)
Range$0.25
Volume757.203K
Dollar Volume$3.32M

Premarket Yesterday

+0.06(+1.33%)
Open$4.50
Close$4.56
Low$4.50
Low Change0.00 (0.00%)
High$4.73
High Change+0.23 (+5.11%)
Range$0.23
Volume667
Dollar Volume$3.04K

Relmada Therapeutics Top Trades

Relmada Therapeutics's top trade so far today returned +2.66%, while the top short trade returned -0.69%.

Relmada Therapeutics Moving Averages

5 Day Moving Average (SMA5)$4.41
10 Day Moving Average (SMA10)$4.50
20 Day Moving Average (SMA20)$4.62
50 Day Moving Average (SMA50)$5.34
100 Day Moving Average (SMA100)$6.16
200 Day Moving Average (SMA200)$5.48

Relmada Therapeutics Statistics

Average Volume (30 Days)1.14M
P/E Ratio (Current)-7.83
EPS (Current)-$0.58
Dividend Yield0.00%
Free Cash Flow-$45.99M
Cash Ratio1.53
Current Ratio29.52
Quick Ratio29.52
Debt to Equity0.00
Enterprise Value$472.95M
EV to EBITDA-7.26
EV to Sales
Price to Book2.34
Price to Cash Flow
Price to Free Cash Flow
Price to Sales
Return on Assets-0.28%
Return on Equity-0.30%

Relmada Therapeutics Stock Splits

There have been 2 stock splits for Relmada Therapeutics (RLMD). The last reverse stock split occured on September 30, 2019 and reduced the outstanding shares at a ratio of 4:1.

DateTypeRatio
Sep 30, 2019Reverse4:1
Aug 12, 2015Reverse5:1

Relmada Therapeutics Dividends

There have been no dividends for Relmada Therapeutics (RLMD).